Related Experiment Video
Updated: Jul 15, 2026
06:56
Isolation of Double Negative αβ T Cells from the Kidney
Published on: May 16, 2014
Block and tackle: CTLA4Ig takes on lupus
A Davidson1, B Diamond, D Wofsy
1Department of Medicine, Columbia University, New York, NY, USA. ad2247@columbia.edu
Lupus
|April 6, 2005
Summary
Blockade of costimulatory signals using CTLA4Ig shows promise for treating autoimmune diseases like systemic lupus erythematosus (SLE). This approach prevents disease onset in mice and can induce remission, supporting clinical trials in SLE patients.
Area of Science:
- Immunology
- Autoimmune Diseases
- Therapeutic Development
Background:
- Antigen nonspecific costimulatory signals play a role in autoimmune diseases.
- CTLA4Ig, a CD28/B7 interaction antagonist, is a potential therapeutic agent.
- Systemic lupus erythematosus (SLE) is a target autoimmune disease.
Purpose of the Study:
- To review the mechanisms of action of CTLA4Ig.
- To discuss the preclinical efficacy of CTLA4Ig in murine SLE models.
- To evaluate the rationale for clinical trials of CTLA4Ig in SLE patients.
Main Methods:
- Review of existing literature on CTLA4Ig.
- Analysis of preclinical data in murine models of SLE.
- Assessment of CTLA4Ig's role in normal immunity and autoimmune disease.
Main Results:
- CTLA4Ig prevents SLE onset in murine models.
- Combination therapy with cyclophosphamide induces remission in active SLE nephritis.
- CTLA4Ig modulates immune responses relevant to autoimmune diseases.
Conclusions:
- CTLA4Ig is a promising therapeutic strategy for SLE.
- Further research is needed to fully understand CTLA4Ig's mechanisms.
- Clinical trials in SLE patients are warranted based on preclinical data.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...